Chondroitin sulfate proteoglycan 4 as a target for chimeric antigen receptor-based T-cell immunotherapy of solid tumors.
about
CSPG4: a prototype oncoantigen for translational immunotherapy studies.Targeting tumor-associated carbohydrate antigens: a phase I study of a carbohydrate mimetic-peptide vaccine in stage IV breast cancer subjects.NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL.The Significance of Chondroitin Sulfate Proteoglycan 4 (CSPG4) in Human Gliomas
P2860
Chondroitin sulfate proteoglycan 4 as a target for chimeric antigen receptor-based T-cell immunotherapy of solid tumors.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Chondroitin sulfate proteoglyc ...... immunotherapy of solid tumors.
@en
type
label
Chondroitin sulfate proteoglyc ...... immunotherapy of solid tumors.
@en
prefLabel
Chondroitin sulfate proteoglyc ...... immunotherapy of solid tumors.
@en
P2093
P2860
P1476
Chondroitin sulfate proteoglyc ...... immunotherapy of solid tumors.
@en
P2093
Claudia Geldres
Gianpietro Dotti
Soldano Ferrone
Yangyang Wang
P2860
P304
P356
10.1517/14728222.2015.1068759
P407
P577
2015-07-18T00:00:00Z